Biotech executives say President Trump’s ‘misguided’ travel ban will harm the industry By: MarketWatch February 07, 2017 at 12:35 PM EST Employees now fear deportation, biotech executives said. Read More >> Related Stocks: AbbVie Acorda Therapeutics Allergan Plc Alnylam Pharmaceuticals Amgen Biogen Idec Cerus Corp Ironwood Pharmaceuti Johnson & Johnson Juniper Pharm Inc Merck & Co Oncomed Pharma Pfizer Standard & Poors 500